- Home
- UNH vs NVO Comparison
UNH vs NVO Comparison
Compare UNH & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNH
- NVO
- Stock Information
- Founded
- UNH 1977
- NVO 1923
- Country
- UNH United States
- NVO Denmark
- Employees
- UNH N/A
- NVO N/A
- Industry
- UNH Medical Specialities
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UNH Health Care
- NVO Health Care
- Exchange
- UNH Nasdaq
- NVO Nasdaq
- Market Cap
- UNH 545.0B
- NVO 530.0B
- IPO Year
- UNH 1984
- NVO N/A
- Fundamental
- Price
- UNH $500.47
- NVO $85.01
- Analyst Decision
- UNH Strong Buy
- NVO Strong Buy
- Analyst Count
- UNH 20
- NVO 5
- Target Price
- UNH $617.63
- NVO $144.20
- AVG Volume (30 Days)
- UNH 6.8M
- NVO 7.4M
- Earning Date
- UNH 01-10-2025
- NVO 02-05-2025
- Dividend Yield
- UNH 1.68%
- NVO 1.70%
- EPS Growth
- UNH N/A
- NVO 26.84
- EPS
- UNH 15.38
- NVO 3.17
- Revenue
- UNH $393,898,000,000.00
- NVO $40,469,178,712.00
- Revenue This Year
- UNH N/A
- NVO $25.02
- Revenue Next Year
- UNH $7.64
- NVO $20.47
- P/E Ratio
- UNH $32.51
- NVO $25.69
- Revenue Growth
- UNH 9.42
- NVO 26.15
- 52 Week Low
- UNH $436.38
- NVO $81.50
- 52 Week High
- UNH $630.73
- NVO $148.15
- Technical
- Relative Strength Index (RSI)
- UNH 34.07
- NVO 19.70
- Support Level
- UNH $475.82
- NVO $104.14
- Resistance Level
- UNH $506.54
- NVO $109.04
- Average True Range (ATR)
- UNH 20.59
- NVO 2.37
- MACD
- UNH -8.16
- NVO -1.52
- Stochastic Oscillator
- UNH 16.77
- NVO 11.32
About UNH UnitedHealth Group Incorporated (DE)
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 50 million members globally, including 1 million outside the us as June 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.